Kanti Sahu, Rishita Pathak, Naveen Agrawal, Pinkesh Banjare, Harish Sharma, Gyanesh Sahu
Kanti Sahu*, Rishita Pathak, Naveen Agrawal, Pinkesh Banjare, Harish Sharma, Gyanesh Sahu
Shri Shankaracharya Technical Campus, Shri Shankaracharya Group of Institutions, Faculty of Pharmaceutical Sciences, Junwani, Bhilai, Dist-Durg (C.G.) India.
Volume - 11,
Issue - 3,
Year - 2019
Cancer is a major public health problem and a main cause of death worldwide. Cancer is a main health problem in world that causes ‘morbidity and mortality’ in both children and adults. Novel drug delivery strategies are needed to meet the complex challenges associated to cancer therapy. Chemotherapy is a first-line treatment for higher stage of cancer. Liposomes provide a platform to carefully include and transport different therapeutic agents across the human body with sufficient blood motion time. The discovery liposomes have been widely used in biomedical research. Liposomes is slow and uncontrolled, resulting in sublethal concentrations of free drug in the tumor and poor therapeutic efficacy. Nanoparticles also play a important role in diagnostic and treatment of bioavailability, optimize pharmacokinetics, and decrease dosing constancy of drugs and genes. Nanotechnology is an originate and assuring field that uses nanoparticles (NPs) to promote the examination and treatment of cancer. Cancer. Drug delivery systems beyond the nano, micro, and macroscales can extend half-life, improve.
Cite this article:
Kanti Sahu, Rishita Pathak, Naveen Agrawal, Pinkesh Banjare, Harish Sharma, Gyanesh Sahu. A Review of the Novel Drug Delivery System used in the Treatment of Cancer. Res. J. Pharma. Dosage Forms and Tech.2019; 11(3):199-205. doi: 10.5958/0975-4377.2019.00035.1